1999 (5 POSTS)
Lilliehook C, Choksi NY , Hof P, Choi EK, Zaidi NF, Wasco W, et al. Characterization of the presenilin-binding protein calsenilin. Poster presented at Society for Neuroscience Annual Meeting, 1999
View Abstract
Topics: transcriptomics
Fang Y, Choksi NY , Parvathy S, Yamin JJ, Wasco W, Buxbaum JD. Proteins interacting with the COOH-termini of the presenilins. Poster presented at Society for Neuroscience Annual Meeting, 1999.
View Abstract
Topics: toxicokinetics
Choksi NY , Mukherjeree P, Lindroth A, Xiang Z, Wasco W, Buxbaum JD, Pasinetti GM. Cyclooxygenase (COX)-2 expression is associated with presenilin-2 induced apoptosis. Poster presented at Society for Neuroscience Annual Meeting, 1999.
Topics: toxicokinetics
1998 (2 POSTS)
Kodavanti PR, Derr-Yellin EC, Mundy WR, Shafer TJ, Herr DW, Barone S, Choksi NY , MacPhail RC, Tilson HA. 1998. Repeated exposure of Aroclor 1254 causes brain region-specific changes in intracellular Ca2+ buffering and protein kinase C activity in the absence of changes in tyrosine hydroxylase. Toxicol Appl Pharmacol 153(2):186–198; doi: 10.1006/taap.1998.8533 . PMID: 9878590.
View Abstract
Topics: PCBs
Booth RB, Brown RL, Bucholtz ED, Choksi NY , Owens CE, Wyrick S.D. Phenylaminotetralins: A new class of histamine H1-type ligands that affect catecholamine synthesis and release in vitro and in vivo. Society for Neuroscience Abstracts, 24:1838, 1998
View Abstract
Topics: pharmacology
1997 (2 POSTS)
Choksi NY , Kodavanti PRS, Tilson H, Booth RG. 1997. Effects of polychlorinated biphenyls on brain tyrosine hydroxylase activity in rats. Fundam Appl Toxicol 39(1):76–80; doi: 10.1006/faat.1997.2351 . PMID: 9325030.
View Abstract
Topics: PCBs
Choksi NY , Wyrick SD, Booth RG. Phenylaminotetralins modulate dopamine synthesis in rat nucleus accumbens in vivo by a presynaptic H1-type receptor. Poster presented at Society for Neuroscience Annual Meeting, 1997.
View Abstract
Topics: pharmacology
1996 (2 POSTS)
Choksi NY , Hussain A, Booth RG. 1996. 2-Phenylaminoadenosine stimulates adenylyl cyclase activity and dopamine biosynthesis through an A2 receptor mediated mechanism. Brain Res 761(1):151–155; doi: 10.1016/s0006-8993(97)00445-9 . PMID: 9247078.
View Abstract
Topics: drug development
Choksi NY , Wyrick SD, Booth RG. Modulation of brain dopamine synthesis in vivo by a putative σ 3 agonist via a G-protein coupled receptor mechanism. Poster presented at Society for Neuroscience Annual Meeting, 1996
View Abstract
Topics: genotoxicity
1995 (2 POSTS)
Choksi NY , Waller CL, Booth RG. Neurotoxic and neuroprotective effects of polychlorinated biphenyls and adenosine compounds in rat brain. Presented at Society for Neuroscience Annual Meeting, San Diego, CA, November 1995.
View Abstract
Topics: PCBs
Prioleau C, Montague DM, Choksi NY , Southerland SB, Lawler CP, Mailman RB. Unusual neurochemical properties of the novel antipsychotic OPC-14597 in rat striatum. Poster presented at Society for Neuroscience Annual Meeting, 1995.
View Abstract
Topics: drug interactions
1994 (2 POSTS)
Choksi NY , Hussain A, Owens CE, Myers AM, Harvey RD, Baldessarini RJ, Wyrick SD, Booth RG. Adenosine A2 and PAT- σ3 agonists affect adenylyl cyclase activity and dopamine synthesis. Poster presented at North Carolina Society for Neuroscience Meeting, 1994.
Topics: drug interactions
Choksi NY , Hussain A, Myers AM, Owens CE, Harvey RD, Wyrick SD, Baldessarini RJ, Booth RG. Stimulation of brain cAMP and dopamine synthesis by adenosine A2 and σ3 agonists. Poster presented at Society for Neuroscience Annual Meeting, 1994
View Abstract